| 前收市價 | 7.55 |
| 開市 | 7.50 |
| 買盤 | 7.47 x 100 |
| 賣出價 | 7.53 x 200 |
| 今日波幅 | 7.28 - 7.66 |
| 52 週波幅 | 6.06 - 14.34 |
| 成交量 | |
| 平均成交量 | 636,839 |
| 市值 | 407.254M |
| Beta 值 (5 年，每月) | 0.95 |
| 市盈率 (最近 12 個月) | 2.53 |
| 每股盈利 (最近 12 個月) | 2.97 |
| 業績公佈日 | 2024年5月07日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 17.78 |
Barrons.comBuy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.
Voyager Therapeutics has surely tried investors’ patience since it came public eight years ago. The biotech firm’s stock has fallen as low as $2.50 from a peak of $30, as its early programs to treat neurological diseases didn’t pan out. Analysts at Guggenheim Securities initiated coverage of the Lexington, Mass.-based biotech with a Buy rating earlier this week.
Insider Monkey12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]
Insider MonkeyVoyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript February 28, 2024 Voyager Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.25, expectations were $-0.59. Voyager Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. Thank you […]
